DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

June 16, 2020

Study Completion Date

June 16, 2020

Conditions
Peripheral Vascular Disease
Interventions
DEVICE

Medtronic HawkOne® or TurboHawk™

Use of FDA Cleared Directional Atherectomy (DA) Devices. Medtronic HawkOne® Directional Atherectomy System or TurboHawk™ Plaque Excision System. DA followed by DCB will be performed in all enrolled subjects.

DEVICE

Medtronic IN.PACT® Admiral® DCB

FDA Approved Drug Coated Balloon (DCB) Technology. Medtronic IN.PACT® Admiral® DCB will be used after DA.

DEVICE

Medtronic Spider™ Distal Protection Device (DPD)

It is recommended that the Medtronic Spider™ Distal protection device (DPD) be paired with DA when used in complex, calcified lesions (TurboHawk™ IFU).

DEVICE

"Volcano Visions® PV .014 IVUS catheter"

"Lesion IVUS assessment using the Volcano Visions® PV .014 IVUS catheter will be required in all cases."

DEVICE

Nitinol Stent Placement

Only FDA approved nitinol stents can be used if provisional stenting is required.

Trial Locations (7)

2135

St. Elizabeth's, Boston

10029

Mount Sinai, New York

27607

Rex, Raleigh

39216

University of Mississippi, Jackson

50309

Iowa Methodist Medical Center, Des Moines

75605

Longview Cardiac and Vascular Consultants, Longview

78756

Austin Heart, Austin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

VIVA Physicians

OTHER